AOD-9604

Fat burning peptide fragment

$225/mo

Virtual consult required

This peptide requires a brief virtual visit before our team can prescribe.

Details

Virtual Consult

Our licensed provider reviews your health profile via secure video — typically 10 minutes. Required for any peptide prescription.

Refund Policy: If found not eligible due to health reasons after consultation, you will receive a full refund.

Product Details

About AOD-9604

Mechanism of Action

AOD-9604 is a modified fragment (amino acids 176-191) of human growth hormone that retains fat-reducing properties while eliminating HGH side effects like insulin resistance. It stimulates lipolysis while inhibiting lipogenesis, binding to beta-3 adrenergic receptors to activate hormone-sensitive lipase. Shows preferential action on visceral fat deposits.

Scientific Background

Developed at Monash University in the 1990s, AOD-9604 isolates HGH's fat-reducing effects without affecting glucose levels or promoting insulin resistance. Clinical trials showed significant fat loss without adverse HGH effects. Also demonstrates potential for cartilage regeneration and anti-inflammatory properties.

Clinical Applications

Used for fat loss and body composition optimization. Results noticeable within 4-6 weeks, optimal at 12-16 weeks. Particularly effective when combined with nutrition and exercise. Can be combined with CJC-1295 and Ipamorelin for synergistic effects. Does not cause jitteriness, increased heart rate, or sleep disturbances like stimulant fat burners.

Evidence-Based

Clinical Research & Studies

Backed by peer-reviewed research from leading medical journals

2001

Peer Reviewed

Human obesity: functional peptide encoded by the growth hormone gene

This foundational study demonstrated that the C-terminal fragment of growth hormone (AOD-9604) retains lipolytic activity while eliminating other biological actions of HGH, providing a targeted approach to fat reduction without metabolic side effects.

Read Full Study

2004

Peer Reviewed

Anti-obesity and lipid lowering activity of growth hormone fragment AOD-9604

Clinical trial showing AOD-9604 reduced body fat in obese individuals without affecting insulin sensitivity or glucose metabolism, with participants experiencing average body fat reduction of 2.6% over 12 weeks.

Read Full Study

2013

Peer Reviewed

Regenerative effects of AOD9604 on articular cartilage

Research revealing AOD-9604's potential in cartilage repair and osteoarthritis treatment, demonstrating the peptide's ability to stimulate cartilage cell proliferation and matrix synthesis.

Read Full Study

AOD-9604

About AOD-9604

How It Works

Mechanism of Action

Scientific Background

Clinical Applications

Key Benefits

Treatment Protocol

Safety & Considerations

Clinical Research & Studies

Human obesity: functional peptide encoded by the growth hormone gene

Anti-obesity and lipid lowering activity of growth hormone fragment AOD-9604

Regenerative effects of AOD9604 on articular cartilage

Related Resources

Similar Peptide Therapies

MOTS-c

CJC-1295

Tesamorelin/Ipamorelin

Educational Articles

Peptide Therapy for Targeted Fat Loss: AOD-9604 Explained

Body Recomposition: The Science of Losing Fat While Building Muscle